This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.89% per year. These returns cover a period from January 1, 1988 through March 3, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
stock-price-movement: Archive
CyberArk (CYBR) Upgraded to Buy: Here's Why
by Zacks Equity Research
CyberArk (CYBR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
CYBRNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
GENEDX HOLDINGS (WGS) Upgraded to Buy: Here's Why
by Zacks Equity Research
GENEDX HOLDINGS (WGS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
WGSNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
All You Need to Know About Alignment Healthcare (ALHC) Rating Upgrade to Buy
by Zacks Equity Research
Alignment Healthcare (ALHC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
ALHCPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
1st Source (SRCE) Upgraded to Buy: Here's Why
by Zacks Equity Research
1st Source (SRCE) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
SRCENegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
First Financial (FFBC) Upgraded to Buy: Here's What You Should Know
by Zacks Equity Research
First Financial (FFBC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
FFBCNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
TripAdvisor (TRIP) Upgraded to Buy: What Does It Mean for the Stock?
by Zacks Equity Research
TripAdvisor (TRIP) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
TRIPNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Eldorado Gold Corporation (EGO) Now Trades Above Golden Cross: Time to Buy?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
EGOPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
CG Oncology, Inc. (CGON) Surges 25.0%: Is This an Indication of Further Gains?
by Zacks Equity Research
CG Oncology, Inc. (CGON) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
CGONNo Net Change QUREPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Hitachi (HTHIY) is on the Move, Here's Why the Trend Could be Sustainable
by Zacks Equity Research
Hitachi (HTHIY) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
HTHIYNegative Net Change
price-performance stock-price-change stock-price-movement
Bridgewater (BWB) is on the Move, Here's Why the Trend Could be Sustainable
by Zacks Equity Research
Bridgewater (BWB) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
BWBPositive Net Change
price-performance stock-price-change stock-price-movement
Neonode (NEON) Is a Great Choice for 'Trend' Investors, Here's Why
by Zacks Equity Research
Neonode (NEON) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
NEONNegative Net Change
price-performance stock-price-change stock-price-movement
Here's What Could Help Mitsubishi Electric (MIELY) Maintain Its Recent Price Strength
by Zacks Equity Research
If you are looking for stocks that are well positioned to maintain their recent uptrend, Mitsubishi Electric (MIELY) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
MIELYPositive Net Change
price-performance stock-price-change stock-price-movement
Recent Price Trend in Intercorp Financial Services (IFS) is Your Friend, Here's Why
by Zacks Equity Research
Intercorp Financial Services (IFS) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
IFSNegative Net Change
price-performance stock-price-change stock-price-movement
Recent Price Trend in Idaho Strategic Resources (IDR) is Your Friend, Here's Why
by Zacks Equity Research
Idaho Strategic Resources (IDR) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
IDRNegative Net Change
price-performance stock-price-change stock-price-movement
Urogen Pharma (URGN) Moves 14.1% Higher: Will This Strength Last?
by Zacks Equity Research
Urogen Pharma (URGN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
URGNPositive Net Change LQDAPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Esquire Financial (ESQ) Upgraded to Buy: Here's Why
by Zacks Equity Research
Esquire Financial (ESQ) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
ESQNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Adidas (ADDYY) Upgraded to Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Adidas (ADDYY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
ADDYYNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
PAVmed (PAVM) Upgraded to Buy: Here's What You Should Know
by Zacks Equity Research
PAVmed (PAVM) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
PAVMNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
What Makes Supernus (SUPN) a New Buy Stock
by Zacks Equity Research
Supernus (SUPN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
SUPNNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
All You Need to Know About South Plains Financial (SPFI) Rating Upgrade to Strong Buy
by Zacks Equity Research
South Plains Financial (SPFI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
SPFINegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Matson (MATX) Upgraded to Buy: Here's What You Should Know
by Zacks Equity Research
Matson (MATX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
MATXPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
All You Need to Know About Pegasystems (PEGA) Rating Upgrade to Strong Buy
by Zacks Equity Research
Pegasystems (PEGA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
PEGAPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Associated Banc-Corp (ASB) Upgraded to Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Associated Banc-Corp (ASB) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
ASBNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Eastern Bankshares (EBC) Upgraded to Buy: Here's Why
by Zacks Equity Research
Eastern Bankshares (EBC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
EBCNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Pitney Bowes (PBI) Upgraded to Buy: Here's Why
by Zacks Equity Research
Pitney Bowes (PBI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
PBIPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank